Parabolic Drugs Ltd

Parabolic Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Parabolic Drugs Ltd

₹ 5.50 -4.35%
25 Jan 2021
parabolicdrugs.com BSE: 533211 NSE: PARABDRUGS
About

Parabolic Drugs engages in the manufacture and contract manufacture of active pharmaceutical ingredients (API) and API intermediates.

[ add key points ]
Website BSE NSE - BZ
  • Market Cap ₹ 34.0 Cr.
  • Current Price ₹ 5.50
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -150
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
16.39 16.23 12.85 4.97 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20.89 19.37 17.71 10.90 2.27 1.95 1.95 1.71 1.71 1.71 1.71 0.44 0.84
Operating Profit -4.50 -3.14 -4.86 -5.93 -2.01 -1.95 -1.95 -1.71 -1.71 -1.71 -1.71 -0.44 -0.84
OPM % -27.46% -19.35% -37.82% -119.32% -773.08%
-0.04 0.02 0.13 0.66 0.01 -1.88 0.01 0.00 0.00 0.00 0.00 0.27 0.23
Interest 1.90 2.09 1.26 2.70 0.05 -0.54 0.16 0.17 0.17 0.17 0.17 0.46 0.34
Depreciation 8.65 8.59 5.73 5.67 5.14 5.97 5.56 5.34 5.34 5.34 5.34 4.85 5.10
Profit before tax -15.09 -13.80 -11.72 -13.64 -7.19 -9.26 -7.66 -7.22 -7.22 -7.22 -7.22 -5.48 -6.05
Tax % 2.58% 3.41% -10.24% 5.21% -1.39% 1.84% -2.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-15.48 -14.27 -10.52 -14.35 -7.09 -9.43 -7.49 -7.22 -7.22 -7.22 -7.22 -5.48 -6.05
EPS in Rs -2.50 -2.31 -1.70 -2.32 -1.15 -1.52 -1.21 -1.17 -1.17 -1.17 -1.17 -0.89 -0.98
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
395 513 617 919 763 438 231 75 73 71 18 0 0
335 430 515 762 836 519 310 381 118 87 33 6 5
Operating Profit 60 83 102 157 -73 -82 -78 -306 -46 -15 -15 -6 -5
OPM % 15% 16% 17% 17% -10% -19% -34% -410% -62% -22% -82%
2 5 15 4 6 13 1 0 4 4 -1 0 0
Interest 28 38 41 64 73 83 99 108 10 9 3 1 1
Depreciation 4 6 8 31 55 68 73 67 53 35 23 22 21
Profit before tax 30 44 69 66 -195 -220 -249 -481 -105 -55 -42 -29 -26
Tax % 20% 22% 23% 23% -28% -40% 52% 1% 3% 3% -1% 0%
24 34 53 51 -140 -132 -379 -485 -108 -57 -41 -29 -26
EPS in Rs 8.54 8.27 -22.58 -21.28 -61.29 -78.39 -17.46 -9.21 -6.69 -4.63 -4.21
Dividend Payout % 0% 0% 6% 3% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: 14%
3 Years: 20%
TTM: 12%
Stock Price CAGR
10 Years: -7%
5 Years: 56%
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
Equity Capital 11 37 62 62 62 62 62 62 62 62 62 62 62
Reserves 89 121 317 367 239 121 -258 -743 -851 -908 -949 -977 -990
289 421 474 555 777 842 957 972 979 984 985 157 158
121 111 214 331 161 202 189 287 303 281 275 1,108 1,109
Total Liabilities 510 690 1,067 1,314 1,239 1,227 950 577 493 419 372 349 339
97 130 163 188 334 331 395 371 349 326 298 278 267
CWIP 19 41 112 187 72 81 7 7 7 7 7 7 7
Investments 2 2 6 4 6 6 6 6 6 6 6 6 6
392 517 786 936 827 809 542 193 132 80 62 59 59
Total Assets 510 690 1,067 1,314 1,239 1,227 950 577 493 419 372 349 339

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
-40 -31 3 207 -111 28 -4 90 2 3
-56 -87 -180 -205 -108 -30 -16 1 0 1
103 122 186 7 197 -4 17 -93 -2 -4
Net Cash Flow 6 4 8 9 -23 -6 -3 -2 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Debtor Days 135 137 163 88 66 124 155 342 335 148 562
Inventory Days 234 239 276 237 167 363 450 45 61 91 12
Days Payable 123 82 137 149 59 187 146 104 420 465 1,325
Cash Conversion Cycle 246 294 302 176 174 301 460 283 -24 -226 -751
Working Capital Days 225 255 263 154 206 301 454 -535 -766 -864 -3,645
ROCE % 19% 17% 15% 14% -12% -13% -17% -71% -39% -28% -31%

Shareholding Pattern

Numbers in percentages

Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020
37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79% 37.79%
8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06% 8.06%
0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.59% 0.58% 0.58% 0.58% 0.58%
53.57% 53.57% 53.57% 53.57% 53.57% 53.57% 53.57% 53.56% 53.57% 53.57% 53.57% 53.57%
No. of Shareholders 13,13213,09513,04412,95912,89912,82412,79412,86712,88513,22613,36013,652

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings